Live feed
Filing
SC 13D/A
SC 13D/A0001193125-23-216053·Astellas Pharma Inc.
Schedule 13D ownership disclosure
Taysha Gene Therapies Inc
Security class unavailable · CUSIP: 877619106
Event date: 2023-08-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.8900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-216053
- Form type
- SC 13D/A
- Filer
- Astellas Pharma Inc.
- CIK
- CIK 1376684
- Filed
- Aug 18, 2023
- Reporting period
- Aug 16, 2023
- Description
- Schedule 13D beneficial ownership